Clearpoint Neuro Inc (CLPT) Financials

$14.05

$0.09 (0.64%)

As on 08-Sep-2026 16:11EDT

Market cap

$426 Mln

Revenue (TTM)

$42 Mln

P/E Ratio

--

P/B Ratio

39.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	42.28	36.97	31.39	23.96	20.55	16.30
Cost of Revenue	15.81	14.28	12.27	10.34	7.02	5.18
Gross Profit	26.47	22.69	19.12	13.61	13.53	11.12
Operating Expenses	57.51	46.86	38.87	36.06	29.86	24.50
Operating Profit (EBIT)	-31.04	-24.16	-19.75	-22.45	-16.33	-13.37
Other Income	--	--	--	--	-0.02	-0.06
Profit before Tax	-34.58	-25.49	-18.91	-22.09	-16.44	-14.41
Provision for Tax	-0.02	0.06	-18.91	1.29	0.10	0.91
Profit after Tax (Net Income)	-34.57	-25.54	-18.91	-22.09	-16.44	-14.41
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-16.44	-14.41

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10.78	28.02	25.39	21.17	36.89	48.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	65.65	58.96	3.45	14.06	11.82	12.04
Current Liabilities	10.31	10.77	10.35	7.43	6.79	4.75
Total Liabilities	97.05	97.75	39.19	42.66	55.49	65.58

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	38.01	34.15	5.83	6.49	4.31	3.69
Current Assets	48.73	63.60	33.36	36.17	51.18	61.89
Total Assets	96.86	97.75	39.19	42.66	55.49	65.58
Total Debt*	63.95	58.23	3.57	13.94	11.99	12.28
Net Current Assets	38.62	52.84	23.01	28.74	44.39	57.14

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-23.93	-8.95	-13.72	-16.17	-12.70
Cash Flow from Investing Activities	--	0.62	-0.28	8.95	-10.74	-0.17
Cash from Financing Activities	--	50.18	6.19	0.30	0.41	46.88
Net Cash Inflow / Outflow	--	--	--	--	-26.49	34.01

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.19	-0.90	-0.70	-0.90	-0.67	-0.64
Cash EPS ($)	--	-0.82	-0.63	-0.85	-0.64	-0.63
Adjusted Book Value ($)	--	0.99	0.94	0.86	1.50	2.17
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.84	-0.33	-0.56	-0.66	-0.56
Free Cash Flow per Share ($)	--	-0.86	-0.34	-0.59	-0.67	-0.57

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.34	-59.04	-52.60	-29.90	-32.91
ROE (%)	-178.19	-95.64	-81.24	-76.09	-38.37	-56.33
ROA (%)	-41.37	-37.30	-46.22	-45.01	-27.15	-30.31
EBIT Margin (%)	-72.91	-62.47	-60.25	-92.21	-79.58	-82.44
Net Margin (%)	-81.76	-69.08	-60.25	-92.21	-80.06	-88.75
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	25.86	0.18	0.31	0.17	0.26	0.27
EBIT Growth (%)	-39.48	-22.12	14.37	-35.07	-21.71	-151.72
Net Profit Growth (%)	-55.54	-35.03	14.37	-34.40	-14.05	-112.47
EPS Growth (%)	-47.50	-0.29	0.22	-0.34	-0.05	-0.58
Book Value Growth (%)	-48.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-15.17	-21.98	-7.57	-12.64	-17.54
Price / Book Value	39.80	13.82	16.37	7.90	5.63	5.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.07	-19.16	-23.46	-7.66	-11.70	-16.55
Close Price ($)	17.84	13.68	15.38	6.79	8.47	11.22
High Price ($)	30.10	30.10	17.47	11.00	16.96	31.29
Low Price ($)	8.27	9.76	5.11	4.05	7.00	10.65
Market Cap ($ Cr)	425.84	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	4.66	2.08	0.14	0.66	0.32	0.25
Short term debt to equity ratio	0.02	0.02	0.02	0.02	0.02	0.01
Current Ratio	4.73	5.91	3.22	4.87	7.54	13.02
Quick Ratio	3.87	5.13	2.56	3.80	6.17	11.98
Interest Coverage	-7.56	-9.67	-36.51	-57.23	-201.90	-13.81

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	22.13	19.65	15.01	16.46	12.97	14.34
Asset Turnover	0.51	0.54	0.77	0.49	0.34	0.34
Receivable days	--	59.16	50.37	50.38	44.45	47.26
Inventory Days	--	194.69	219.93	304.00	370.48	288.47
Payable days	--	33.20	25.80	11.74	18.18	25.65
Cash Conversion Cycle	--	220.64	244.50	342.64	396.74	310.08

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.